Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06581835 · ClinicalTrials.gov registry record

Accuracy Performance Verification of the INVOS™ PM7100 System in Adults

A clinical trial of Oxygen Saturation, sponsored by Medtronic - MITG.

Completed
Registry status
42
Enrollment target
1
Study location

NCT06581835: Completed study of Oxygen Saturation, sponsored by Medtronic - MITG.

NCT06581835 is a study of Oxygen Saturation that has completed, run by Medtronic - MITG. The registered enrollment target is 42 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06581835, a study of Oxygen Saturation, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
42 participants
Enrollment target
1
Study location

Study Summary

Prospective, observational, post-market, verification study to ensure compliance to the ISO 80601-2-85:2021 standard

Primary Outcome

Accuracy root mean square is the square-root of the average squared distances between regional oxygen saturation (rSO2) as measured by INVOS and and field saturation (fSO2) as measured by blood sampling

Conditions Studied

Interventions

  • DEVICE Observational

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2024-10-21
Est. Completion 2025-07-22
Medtronic - MITG

119 total trials

What the finished NCT06581835 record still lists

NCT06581835 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 42 participants, a relatively small participant target.

The record links to 1 condition, with Oxygen Saturation appearing as the primary indexed condition, and to 1 intervention - of which Observational is the first listed.

NCT06581835 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT06581835 about?

NCT06581835 is a clinical study titled "Accuracy Performance Verification of the INVOS™ PM7100 System in Adults". Prospective, observational, post-market, verification study to ensure compliance to the ISO 80601-2-85:2021 standard

What is the current status of trial NCT06581835?

This trial is currently completed. The enrollment target is 42 participants. The study started on 2024-10-21. Estimated completion is 2025-07-22.

What conditions does trial NCT06581835 study?

This clinical trial studies the following conditions: Oxygen Saturation.

What interventions are being tested in trial NCT06581835?

The interventions under investigation include: Observational (DEVICE).

Who is sponsoring clinical trial NCT06581835?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06581835 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Oxygen Saturation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06581835, the US trial registry maintained by the National Library of Medicine. NCT06581835 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.